NVIDIA Corp (NVDA)

Nebius is one of the fastest-growing businesses in AI infrastructure, but it's pricey.

The stock would need to grow at an annualized rate of around 16% to get to a $10 trillion market cap in four years.

Micron's AI boom is only part of the story. If you follow the power, you may find the next group of overlooked AI winners.

CoreWeave's latest quarterly results make it clear that strong AI data center demand will ensure healthy long-term growth for the company.

BlackRock, DLocal, Chevron, Williams Companies, and MetLife pay solid dividends and carry favorable analyst ratings, offering income investors growth exposure and price target upside.

NVIDIA and SB Energy partner to build an 8 IT-GW AI campus in Ohio for OpenAI, backed by a $1.5B investment.

Trane Technologies and Eaton developed an integrated design for NVIDIA’s DSX AI Factory, targeting faster development and more efficient AI data centers.

Billionaire investor David Tepper initiated a new CoreWeave stake in Q2 while adding to Nvidia, Amazon and TSMC.

Investors that bought this booming exchange-traded fund a decade ago and held on have benefited from the success of the technology sector.

A series filings show the massive stakes tech giants Nvidia and Alphabet and mega investors Peter Thiel have in SpaceX.

SiTime's strong Q2 2026 earnings beat highlight rising AI infrastructure demand for enabling technologies, also lifting comparable niche semiconductor firms FormFactor and Cognex.

Jim Cramer slams the "ill-advised" White House block on Nvidia chips, warning it predictably fueled China's push for global AI dominance.

Just be sure to look more than a year down the road.

The S&P 500 returned 9.5% annually over the past two decades. Wall Street expects much bigger gains in the next year.

In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a

The semiconductor fund compressed about six years of its normal return into one. Its own history has seen only two runs anything like it.

Recursion Pharmaceuticals (NASDAQ:RXRX) is using artificial intelligence to generate and analyze biological data in an effort to improve drug discovery, advance internal therapeutic programs and support collaborations with larger pharmaceutical companies, CFO and President of Recursion U.K. Ben Tayl

Over the past six months, Lazard’s stock price fell to $44.64. Shareholders have lost 13.6% of their capital, which is disappointing considering the S&P 500 ...

Rumble (NASDAQ:RUM) is positioning its recently combined operations as an AI compute infrastructure business with a substantial 2027 power pipeline, while continuing to operate its established video platform separately. Speaking at an event with Canaccord Genuity Equity Research Senior Analyst King

Jensen Huang has a unique ability to drive investment in his industry.

Electronic measurement provider Keysight (NYSE:KEYS) will be announcing earnings results this Tuesday after market hours. Here’s what you need to know. Keysi...

The commoditized nature of memory chips has traditionally made companies vulnerable to industry cycles.

The chipmaker's valuation is far higher than those of its peers.

Nvidia and Meta are attacking artificial intelligence from opposite ends. Discover where each moat is strongest, what could weaken it, and why this battle may produce two winners.